within Pharmacolibrary.Drugs.ATC.N;

model N03AB02
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.95,
    Cl             = 2.5e-07,
    adminDuration  = 600,
    adminMass      = 300 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.00065,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0004166666666666667,
    Tlag           = 600
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>N03AB02</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Phenytoin is an antiepileptic drug widely used for the treatment and prevention of seizures, particularly in the management of tonic-clonic (grand mal) and partial seizures. It stabilizes neuronal membranes and decreases seizure activity by increasing efflux or decreasing influx of sodium ions across cell membranes in the motor cortex during generation of nerve impulses. Phenytoin is approved for use in many countries and is still actively used today.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in adult healthy volunteers and patients with epilepsy. Sex: both male and female, age range: adults (18-65 years), without significant renal or hepatic impairment.</p><h4>References</h4><ol><li><p>DeVane, CL, &amp; Nemeroff, CB (2001). Clinical pharmacokinetics of quetiapine: an atypical antipsychotic. <i>Clinical pharmacokinetics</i> 40(7) 509–522. DOI:<a href=\"https://doi.org/10.2165/00003088-200140070-00003\">10.2165/00003088-200140070-00003</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/11510628/\">https://pubmed.ncbi.nlm.nih.gov/11510628</a></p></li><li><p>Zaccara, G, &amp; Perucca, E (2014). Interactions between antiepileptic drugs, and between antiepileptic drugs and other drugs. <i>Epileptic disorders : international epilepsy journal with videotape</i> 16(4) 409–431. DOI:<a href=\"https://doi.org/10.1684/epd.2014.0714\">10.1684/epd.2014.0714</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/25515681/\">https://pubmed.ncbi.nlm.nih.gov/25515681</a></p></li><li><p> (2024). Comparison Table: Some oral antiseizure medications. <i>The Medical letter on drugs and therapeutics</i> 66(1708) e133–e140. DOI:<a href=\"https://doi.org/10.58347/tml.2024.1708b\">10.58347/tml.2024.1708b</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/39073881/\">https://pubmed.ncbi.nlm.nih.gov/39073881</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end N03AB02;
